Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1321 AL 1335

Diffusional kurtosis imaging of cingulate fibers in Parkinson disease: comparison with conventional diffusion tensor imaging

Kamagata K, Tomiyama H, Motoi Y, Kano M, Abe O, Ito K, Shimoji K, Suzuki M, Hori M, Nakanishi A, Kuwatsuru R, Sasai K, Aoki S, Hattori N.

Magn Reson Imaging. 2013 Nov;31(9):1501-6. doi: 10.1016/j.mri.2013.06.009. Epub 2013 Jul 27.

Surgical treatment of Parkinson disease: past, present, and future

Duker AP, Espay AJ.

Neurol Clin. 2013 Aug;31(3):799-808. doi: 10.1016/j.ncl.2013.03.007. Epub 2013 Apr 4.

Effect of diclofenac and antidepressants on the inflammatory response in astrocyte cell culture

Al-Amin MM, Uddin MM, Rahman MM, Reza HM, Rana MS.

Inflammopharmacology. 2013 Dec;21(6):421-5. doi: 10.1007/s10787-013-0181-9. Epub 2013 Jul 30.

The role of α-synuclein in neurodegenerative diseases: from molecular pathways in disease to therapeutic approaches

Al-Mansoori KM, Hasan MY, Al-Hayani A, El-Agnaf OM.

Curr Alzheimer Res. 2013 Jul;10(6):559-68. doi: 10.2174/1567205011310060002.

Control of sleep and wakefulness in health and disease

Zeitzer JM.

Prog Mol Biol Transl Sci. 2013;119:137-54. doi: 10.1016/B978-0-12-396971-2.00006-3.

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

Irwin DJ, Lee VM, Trojanowski JQ.

Nat Rev Neurosci. 2013 Sep;14(9):626-36. doi: 10.1038/nrn3549. Epub 2013 Jul 31.

The Emerging Health Benefits of Coffee with an Emphasis on Type 2 Diabetes and Cardiovascular Disease

Bidel S, Tuomilehto J.

Eur Endocrinol. 2013 Aug;9(2):99-106. doi: 10.17925/EE.2013.09.02.99. Epub 2013 Aug 23.

Dopaminergic influences on executive function and impulsive behaviour in impulse control disorders in Parkinson's disease

Leroi I, Barraclough M, McKie S, Hinvest N, Evans J, Elliott R, McDonald K.

J Neuropsychol. 2013 Sep;7(2):306-25. doi: 10.1111/jnp.12026. Epub 2013 Jul 31.

[An alternative medical approach for the neuroprotective therapy to slow the progression of Parkinson's disease]

Muroyama A.

Yakugaku Zasshi. 2013;133(8):849-56. doi: 10.1248/yakushi.13-00158.

¹²³I-FP-Cit and 123I-IBZM SPECT uptake in a prospective normal material analysed with two different semiquantitative image evaluation tools

Jakobson Mo S, Larsson A, Linder J, Birgander R, Edenbrandt L, Stenlund H, Forsgren L, Riklund K.

Nucl Med Commun. 2013 Oct;34(10):978-89. doi: 10.1097/MNM.0b013e328364aa2e.

Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor

Haleem DJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:170-80. doi: 10.1016/j.pnpbp.2013.07.015. Epub 2013 Jul 29.

Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action

Pierce RC, Vassoler FM.

Psychopharmacology (Berl). 2013 Oct;229(3):487-91. doi: 10.1007/s00213-013-3214-6. Epub 2013 Aug 2.

Costs of Parkinson's disease in a privately insured population

Johnson SJ, Kaltenboeck A, Diener M, Birnbaum HG, Grubb E, Castelli-Haley J, Siderowf AD.

Pharmacoeconomics. 2013 Sep;31(9):799-806. doi: 10.1007/s40273-013-0075-0.

Rasagiline in Parkinson's disease: the show must go on

Jost WH.

Expert Opin Drug Saf. 2013 Nov;12(6):797-800. doi: 10.1517/14740338.2013.823398. Epub 2013 Aug 2.

Mirtazapine improves visual hallucinations in Parkinson's disease: a case report

Tagai K, Nagata T, Shinagawa S, Tsuno N, Ozone M, Nakayama K.

Psychogeriatrics. 2013 Jun;13(2):103-7. doi: 10.1111/j.1479-8301.2012.00432.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias